[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.171.35. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 1,329
Citations 0
Correction
June 14, 2016

Update in Conflict of Interest Disclosures

JAMA. 2016;315(22):2472. doi:10.1001/jama.2016.6792

In the Research Letter entitled “Use of Open Access Platforms for Clinical Trial Data,” published in the March 22/29, 2016, issue of JAMA,1 the disclosures for Drs Pencina and Peterson should also read “that Duke University receives funding for the SOAR Initiative from Bristol-Myers Squibb.” This article was corrected online.

References
1.
Navar  AM, Pencina  MJ, Rymer  JA, Louzao  DM, Peterson  ED.  Use of open access platforms for clinical trial data. JAMA. 2016; 315(12):1283-1284.
PubMedArticle
×